These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2882385)

  • 1. Ifosfamide/mesna encephalopathy.
    McCallum AK
    Lancet; 1987 Apr; 1(8539):987. PubMed ID: 2882385
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible encephalopathy with ifosfamide/mesna.
    Salloum E; Flamant F; Ghosn M; Taleb N; Akatchereian C
    J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
    [No Abstract]   [Full Text] [Related]  

  • 3. Ifosfamide, mesna, and encephalopathy.
    Lancet; 1985 Jun; 1(8442):1398-9. PubMed ID: 2861351
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.
    Steger GG; Dittrich C; Schlappack O; Mader R; Herold C; Brade WP; Keller A; Moser K
    J Cancer Res Clin Oncol; 1988; 114(6):602-4. PubMed ID: 3144554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encephalopathy associated with ifosphamide/mesna therapy.
    Meanwell CA; Blake AE; Latief TN; Blackledge G; Mould JJ; Blake DR; Shaw IC; Honigsberger L; Spooner D; Williams AC
    Lancet; 1985 Feb; 1(8425):406-7. PubMed ID: 2857462
    [No Abstract]   [Full Text] [Related]  

  • 6. Avoiding ifosfamide/mesna encephalopathy.
    Meanwell CA; Kelly KA; Blackledge G
    Lancet; 1986 Aug; 2(8503):406. PubMed ID: 2874408
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe renal failure following high-dose ifosfamide and mesna.
    Willemse PH; de Jong PE; Elema JD; Mulder NH
    Cancer Chemother Pharmacol; 1989; 23(5):329-30. PubMed ID: 2495864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalopathy with rapid infusion ifosfamide/mesna.
    Perren TJ; Turner RC; Smith IE
    Lancet; 1987 Feb; 1(8529):390-1. PubMed ID: 2880199
    [No Abstract]   [Full Text] [Related]  

  • 9. Ifosfamide/mesna and hematuria.
    Pratt CB; Goren MP
    Cancer Treat Rep; 1987 Nov; 71(11):1124-5. PubMed ID: 3119210
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
    Husband DJ; Watkin SW
    Lancet; 1988 May; 1(8594):1116. PubMed ID: 2896952
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of ifosfamide/mesna associated encephalopathy.
    Meanwell CA; Blake AE; Kelly KA; Honigsberger L; Blackledge G
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):815-9. PubMed ID: 3095121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide/mesa and encephalopathy.
    Cantwell BM; Harris AL
    Lancet; 1985 Mar; 1(8431):752. PubMed ID: 2858016
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control.
    Hall G; Lind MJ; Huang M; Moore A; Gane A; Roberts JT; Cantwell BM
    Postgrad Med J; 1990 Oct; 66(780):860-1. PubMed ID: 2129174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
    Matthiessen W; Stempinski E; Göbel D; Thalmann U
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():121-3. PubMed ID: 6414688
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.
    Sanchiz F; Milla A
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S91-2. PubMed ID: 2112057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Encephalopathy caused by an ifosfamide-mesna combination].
    Beuzeboc P; Dorval T; Garcia-Giralt E; Jouve M; Livartowski A; Palangie T; Scholl S; Pouillart P
    Presse Med; 1988 Apr; 17(12):591-2. PubMed ID: 2967486
    [No Abstract]   [Full Text] [Related]  

  • 17. Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
    Ghosn M; Carde P; Leclerq B; Flamant F; Friedman S; Droz JP; Hayat M
    Bull Cancer; 1988; 75(4):391-2. PubMed ID: 3132998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide and ifosfamide: role of uroprotective agents.
    Williams SD; Munshi N; Einhorn LH; Loehrer PJ
    Cancer Invest; 1990; 8(2):269. PubMed ID: 2119246
    [No Abstract]   [Full Text] [Related]  

  • 19. Fatal encephalopathy with ifosfamide/mesna.
    Verdeguer A; Castel V; Esquembre C; Ferris J; Fernandez JM; Ruiz JG
    Pediatr Hematol Oncol; 1989; 6(4):383-5. PubMed ID: 2518327
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuously improving ifosfamide/mesna: a winning combination.
    Anderson P
    Pediatr Blood Cancer; 2010 Oct; 55(4):599-600. PubMed ID: 20589648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.